Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-18T15:06:05.516Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluation of antioxidant treatment in presbyacusis: prospective, placebo-controlled, double-blind, randomised trial

Published online by Cambridge University Press:  15 January 2013

J F Polanski  and
O L Cruz
J F Polanski*
Affiliation:
Division of Otology and Neurotology, Department of Otolaryngology and Head and Neck Surgery, Federal University of São Paulo, Brazil
O L Cruz
Affiliation:
Division of Otology and Neurotology, Department of Otolaryngology and Head and Neck Surgery, Federal University of São Paulo, Brazil
*
Address for correspondence: Dr José Fernando Polanski, Rua Des Westphalen, 289 – 31/32, CEP 80010-110, Curitiba, Brazil Fax: +55 41 3045 9400 E-mail: jfpolanski@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

There are many well-known aetiological mechanisms of presbyacusis, and free radicals have been shown to play an important role. This study aimed to evaluate the effect of antioxidant agents on the hearing threshold of patients with presbyacusis.

Methods:

One hundred and twenty individuals were divided into four groups and received one of the following treatment schemes: ginkgo biloba dry extract, α-lipoic acid plus vitamin C, papaverine chlorhydrate plus vitamin E, or placebo. All participants were evaluated at recruitment and after six months, using pure tone audiometry (at isolated and average frequencies), speech recognition threshold and percentage index of speech recognition.

Results:

The various treatments had no effect on any of the evaluated measures of hearing, either between groups or over time.

Conclusion:

There was no statistically significant change in the hearing threshold after treatment with any of the tested drugs, during the study period.

Keywords

PresbycusisFree RadicalsAntioxidantsTherapy
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 127 , Issue 2 , February 2013 , pp. 134 - 141
Copyright
Copyright © JLO (1984) Limited 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Stedman, TL. Medical Dictionary, 27th edn.Rio de Janeiro: Guanabara Koogan SA, 2003;1280Google Scholar
2Agrawal, Y, Platz, EA, Niparko, JK. Prevalence of hearing loss and differences by demographic characteristics among US adults. Arch Intern Med 2008;168:1522–30CrossRefGoogle ScholarPubMed
3Schuknecht, HF, Gacek, MR. Cochlear pathology in presbycusis. Ann Otol Rhinol Laryngol 1993;102:1–16CrossRefGoogle ScholarPubMed
4Gates, GA, Cooper, JC Jr, Kannel, WB, Miller, NJ. Hearing in the elderly: the Framingham cohort, 1983–1985, part I – basic audiometric test results. Ear Hear 1990;11:247–56CrossRefGoogle ScholarPubMed
5Popelka, MM, Cruickshanks, KJ, Wiley, TL, Tweed, TS, Klein, BE, Klein, R. Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study. J Am Geriatr Soc 1998;46:1075–8CrossRefGoogle ScholarPubMed
6Bared, A, Ouyang, X, Angeli, S, Du, LL, Hoang, K, Yan, D et al. Antioxidant enzymes, presbycusis, and ethnic variability. Otolaryngol Head Neck Surg 2010;143:263–8CrossRefGoogle ScholarPubMed
7Seidman, MD. Effects of dietary restriction and antioxidants on presbyacusis. Laryngoscope 2000;110:727–38CrossRefGoogle ScholarPubMed
8Byers, T, Bowman, B. Vitamin E supplements and coronary heart disease. Nutr Rev 1993;51:333–6CrossRefGoogle ScholarPubMed
9Joachims, HZ, Segal, J, Golz, A, Netzer, A, Goldenberg, D. Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol 2003;24:572–5CrossRefGoogle ScholarPubMed
10Bilska, A, Wlodek, L. Lipoic acid – the drug of the future? Pharmacol Rep 2005;57:570–7Google ScholarPubMed
11Mahadevan, S, Park, Y. Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci 2008;73:14–19CrossRefGoogle ScholarPubMed
12Le, T, Keithley, EM. Effects of antioxidants on the aging inner ear. Hear Res 2007;226:194–202CrossRefGoogle ScholarPubMed
13Cruz, OL, Kasse, CA, Sanchez, M, Barbosa, F, Barros, FA. Serotonin reuptake inhibitors in auditory processing disorders in elderly patients: preliminary results. Laryngoscope 2004;114:1656–9CrossRefGoogle ScholarPubMed
14Durga, J, Verhoef, P, Anteunis, LJ, Schouten, E, Kok, FJ. Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial. Ann Intern Med 2007;146:1–9CrossRefGoogle ScholarPubMed
15Takumida, M, Anniko, M. Radical scavengers for elderly patients with age-related hearing loss. Acta Otolaryngol 2009;129:36–44CrossRefGoogle ScholarPubMed
16Haase, GM, Prasad, KN, Cole, WC, Baggett-Strehlau, JM, Wyatt, SE. Antioxidant micronutrient impact on hearing disorders: concept, rationale, and evidence. Am J Otolaryngol 2011;32:55–61CrossRefGoogle ScholarPubMed
17Liu, XZ, Yan, D. Ageing and hearing loss. J Pathol 2007;211:188–97CrossRefGoogle ScholarPubMed
18Salt, AN, Melichar, I, Thalmann, R. Mechanisms of endocochlear potential generation by stria vascularis. Laryngoscope 1987;97:984–91CrossRefGoogle ScholarPubMed
19Gratton, MA, Schulte, BA. Alterations in microvasculature are associated with atrophy of the stria vascularis in quiet-aged gerbils. Hear Res 1995;82:44–52CrossRefGoogle ScholarPubMed
20Heman-Ackah, SE, Juhn, SK, Huang, TC, Wiedmann, TS. A combination antioxidant therapy prevents age-related hearing loss in C57BL/6 mice. Otolaryngol Head Neck Surg 2010;143:429–34CrossRefGoogle ScholarPubMed
21Bressler, R. Herb-drug interactions: interactions between Ginkgo biloba and prescription medications. Geriatrics 2005;60:30–3Google ScholarPubMed
22Singh, U, Jialal, I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev 2008;66:646–57CrossRefGoogle ScholarPubMed
23Gates, GA, Cobb, JI, D'Agostino, RB, Wolf, PA. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg 1993;119:156–61CrossRefGoogle Scholar
24Friedland, DR, Cederberg, C, Tarima, T. Audiometric pattern as a predictor of cardiovascular status: development of a model for assessment of risk. Laryngoscope 2009;119:473–86CrossRefGoogle Scholar